Latest Operational Expansion News

Elders Limited has finalised the sale of Killara Feedlot to Australian Meat Group, marking a key step in its strategy to reduce net debt.

Ramelius Resources secures a key environmental nod from WA EPA, clearing the Roe Project to advance via a streamlined Part V approval process and setting the stage for early works in late 2026.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

BPH Global Ltd (ASX: BP8) posted its second best monthly seaweed trading result with gross sales of approximately A$391,000 in the twelfth month, pushing aggregate sales beyond A$3.3 million as Indonesian operations scale up post-monsoon.

Harvest Technology Group secures a A$6.5 million two-tranche placement to fund its defence strategy, expand Nodestream, and strengthen its balance sheet ahead of key growth initiatives.

Aroa Biosurgery posted a breakout FY26, beating revenue and EBITDA guidance with a 54% surge in Myriad sales. The company plans significant investments in FY27 to accelerate growth and capitalise on new market opportunities.

IMEXHS has landed a significant public tender in Mexico, deploying its AI-powered Aquila+ radiology platform across 20 hospitals, adding $384,000 in new annual recurring revenue and advancing its Latin American expansion.

HIQ Limited has locked in non-dilutive funding from the Victorian Government to underpin a $4.9 million project expanding its manufacturing and research footprint in Victoria, supporting its global growth ambitions.

Australian Oil Company Limited is raising $250,000 through a Share Purchase Plan priced at $0.0029 per share, including free-attaching options exercisable by mid-2028. The capital will support oil production enhancements and exploration in Queensland's Surat Basin.

ChemX Materials remains suspended from ASX trading since December 2024, with no exploration activity reported in Q1 2026. The company secured an unsecured $1.2 million loan facility to support its recapitalisation and operational needs.

Dotz Nano appoints experienced tech leader Nati Harpaz as CEO amid a A$3.3 million capital raise, with Harpaz personally investing over A$1 million to back the company’s commercial push.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.